Flow cytometry: advantages in immunotherapy clinical trials
Pharmaceutical Technology
AUGUST 24, 2022
More than three decades ago, scientists at the National Cancer Institute began exploring ways to fight cancer using the patient’s immune system. CAGR between 2020 and 2028. It’s used primarily to monitor changes in immune cell phenotype, to monitor therapeutic cells, and to detect and monitor abnormal cells.
52 
Let's personalize your content